Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Zura Bio Limited
Zura Bio to Present at Three Upcoming Investor Conferences in September
September 03, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 13, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants
August 12, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants
August 09, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Commences Warrant Exchange Offer and Consent Solicitation
July 12, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
June 14, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology
June 06, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
June 03, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Participation in June Investor Conferences
May 29, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Robert Lisicki as CEO and Director
April 08, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
March 28, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Participation at March Conferences
March 04, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Participation at February Investor Conferences
February 02, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
January 08, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
January 03, 2024
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok
December 04, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
November 14, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 13, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute
September 12, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 14, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio to Join the Russell 2000® and Russell 3000® Indexes
June 23, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases
April 27, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Zura Bio Announces Appointment of Chief Scientific Officer
April 14, 2023
From
Zura Bio Limited
Via
Business Wire
Tickers
ZURA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit